Drugs / Umbilical cord mesenchymal stem cell-derived extracellular vesicles
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07472270 | Mar → Dec 2026 expected | cirrhosis of liver | Vinmec Research Institute of Stem Cell and Gene Technology | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umbilical cord mesenchymal stem cell-derived extracellular vesicles | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07472270 ↗ |
| Known as | VinEV-3 | “extracellular vesicles derived from umbilical cord mesenchymal stem cells (UC-MSC-EVs; VinEV-3)” NCT07472270 ↗ |
| Modality | Other / unclassified | “extracellular vesicles derived from umbilical cord mesenchymal stem cells” NCT07472270 ↗ |
| Route | Intravenous | “intravenously administered extracellular vesicles derived from umbilical cord mesenchymal stem cells (UC-MSC-EVs; VinEV-3)” NCT07472270 ↗ |